marijuana stock news

Oxis International, Inc. – “Oxis’ Technology is Lightning in a Bottle”

Oxis International, Inc. (OXIS) (OXI.PA) through its wholly owned subsidiary Oxis Biotech, Inc., today published a new blog post on The Chairman’s Blog, written by the Company’s Chairman and Chief Executive Officer, Anthony Cataldo. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his inaugural blog post, Oxis Chairman and Chief Executive Officer Anthony Cataldo, discusses the unmet medical need for effective treatment options for triple negative breast cancer (TNBC) and multiple myeloma. He offers a look into his past experience in leading an evolving biotech company to commercialize a product that has changed the lives of cancer patients and shares how he is advancing upon a similar opportunity with Oxis. Read the full blog post from Mr. Cataldo on TheChairmansBlog.com (https://www.thechairmansblog.com/oxis-international/anthony-cataldo/oxis-technology-is-lightning-in-a-bottle/).

About Oxis International, Inc.

Oxis International, Inc. through its wholly owned subsidiary Oxis Biotech, Inc., develops innovative drugs focused on the treatment of cancer and other unmet medical needs. OXIS’ lead drug candidate, OXS-2175, is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer. In in vitro and in vivo models of TNBC, OXS-2175 demonstrated the ability to inhibit metastasis. OXIS’ lead drug candidate, OXS-4235, also a small molecule therapeutic candidate, targets the treatment of multiple myeloma and associated osteolytic lesions. In in vitro and in vivo models of multiple myeloma and osteoporosis, OXS-4235 demonstrated the ability to kill multiple myeloma cells, and decrease osteolytic lesions in bone.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published.

You May Also Like

$CANK Announces Approval for 3-For-1 Stock Split

Monarch America Inc. Receives Approval and Announces Payment Date for 3-for-1 Stock…

Premier Health Group (PHGI) (PHGRF) and CB2 Insights Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluation

Premier Health and CB2 Insights Move to Second Phase of Primary Care…

$FULL Lines up Q-1 2015 Earnings Release and Conference Call for Nov. 11

Full Circle Capital Corporation Schedules First Quarter Fiscal 2015 Earnings Release and…